FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Cimzia news from FiercePharma

News

UCB's Cimzia app gets data boost

Will rheumatoid arthritis patients soon spell relief C-I-M-Z-I-A? The UCB drug, an anti-TNF biologic, got the FDA nod for Crohn's disease treatment in April, and an app for an arthritis indication is Read more...

Quick Cimzia launch overjoys UCB

UCB Pharma was delirious with glee when it managed to launch its new TNF inhibitor Cimzia for Read more...
Tags: FDA   UCB Pharma   Cimzia  

Press Releases

Cimzia Approved in the US for the Treatment of Moderate to Severe Crohn's Disease

Cimzia Approved in the US for the Treatment of Moderate to Severe Crohn's Disease Administered every four weeks, UCB's pegylated anti-TNFa offers new treatment option for patients with moderate to Read more...

PRESS RELEASE: UCB Group Drug Cimzia Faces EU Delay, Shares Plunge

UCB Group Drug Cimzia Faces EU Delay, Shares Plunge Brussels (BELGIUM), November 16, 2007 at 7:00 am CET - UCB announced today that it has been informed by the European Medicines Agency (EMEA) that Read more...

Get more Cimzia coverage at: